Target intelligence / Profile preview

MT-CO3 pseudogene 29 (MTCO3P29)

Target
MTCO3P29
Molecular classification
Other (Pseudogene)
01

Overview

MT-CO3 pseudogene 29 (MTCO3P29) is a non-coding locus derived from the mitochondrial gene MT-CO3 (mitochondrially encoded cytochrome c oxidase III), but contains sequence alterations or interruptions that render it nonfunctional as a protein-coding gene. MT-CO3 pseudogenes, including MTCO3P29, are remnants of gene duplication or retrotransposition events and do not encode active protein or participate in mitochondrial respiratory chain complex IV function. The prefix "pseudogene" and its designation (29) indicate that it is one of many such nonfunctional copies or fragments in the genome, and not a functional biological target. No evidence suggests it is a therapeutic target or involved in biological pathways, drug response, or disease, outside of hypothetical, rare pseudogene regulatory effects which are not established for MTCO3P29. In contrast, the canonical gene (MT-CO3) encodes cytochrome c oxidase subunit III, a crucial component of mitochondrial complex IV, which has well-established roles in oxidative phosphorylation, electron transport, and diseases such as mitochondrial myopathies and Leber hereditary optic neuropathy (LHON)[1][2][5].

Other names
MTCO3P29mitochondrially encoded cytochrome c oxidase III pseudogene 29cytochrome c oxidase subunit III pseudogene 29

Beyond the preview

Go deeper on MT-CO3 pseudogene 29 (MTCO3P29).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-CO3 pseudogene 29 (MTCO3P29).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call